<ѻý>A Patient's Journey: What Is 'Just Right'?ѻý> In this installment of A Patient's Journey, Howard Wolinsky talks A1C with his primary care physician Nov 24, 2017
<ѻý>ACR Poster Roundup: Novel OA Tx; Cancer and RA Biologicsѻý> Selections from late-breaker poster presentations at rheumatology meeting Nov 08, 2017
<ѻý>mRCC Agents: Similar Outcomes in Cross-Trial Comparisonѻý> PFS, OS not that different between axitinib and cabozantinib Nov 05, 2017
<ѻý>Stool Bacteria May Influence Tx Response in RCCѻý> Also, antibiotic use just before treatment may impact disease progression Nov 05, 2017
<ѻý>Kidney Cancer Patients Take to Twitter for Support, Infoѻý> Social media platform may be useful for trial recruitment, researchers say Nov 05, 2017
<ѻý>Insurance Status Linked to mRCC Survival Oddsѻý> Patients with private insurance get better treatment, have better outcomes Nov 04, 2017
<ѻý>Shared Decision-Making Strategies for Lung Ca Screening Get High Marksѻý> Patient satisfaction high with physician-led and web-based approaches Nov 02, 2017
<ѻý>Salvage Tx with Radioactive Octreotate Effective for Neuroendocrine Tumorsѻý> Overall survival lengthened with salvage therapy Oct 23, 2017
<ѻý>Vets with HCV Might Settle Cancer Controversyѻý> VA experience seems to rule out possible cancer-causing effect of new drugs Oct 23, 2017
<ѻý>92-Gene Assay: Promising for Molecular NET Classificationѻý> Identifies seven NET subtypes for those with uncertain diagnoses Oct 22, 2017
<ѻý>Radionuclide Tx Boosts QoL in Patients with Midgut NETsѻý> 177Lu-dotatate provides significant benefit for global health status and more Oct 22, 2017
<ѻý>Good Outcomes with Cabozantinib in Carcinoid, PNET Tumorsѻý> Treatment associated with objective tumor responses, encouraging PFS Oct 22, 2017
<ѻý>AASLD Liver Meeting Covers a Lot of Groundѻý> New science could 'potentially change the field' Oct 19, 2017
<ѻý>Deep Learning May Help Detect Colon Polypsѻý> Computer-assisted model warrants further research Oct 17, 2017
<ѻý>Antihistamine Improves Quality of Sedation During Colonoscopyѻý> More research needed on diphenhydramine as an adjunct to sedation Oct 17, 2017
<ѻý>Men's Risk for HPV-Related Oral Cancer Soarsѻý> But caution needed in interpreting cross-sectional study, says Perry Wilson, MD Oct 16, 2017 video
<ѻý>Post-Op Gastric Bypass Care Vital for Preventing Anemiaѻý> 10 years after surgery, most who didn't seek post-op care developed anemia Sep 22, 2017
<ѻý>Telemedicine OK for Genetic Testing and Counselingѻý> Trial finds no major difference in psychosocial outcomes Aug 09, 2017
<ѻý>Vince DeVita’s Oncology Opusѻý> Medicine and music share center stage in storied career Jul 26, 2017
<ѻý>Lymphoma Case Reported in MS Patient on Aubagioѻý> First case in medical literature, more found in global surveillance reports Jul 07, 2017
<ѻý>Pearls from: Fatima Cardoso, MD: Part 1ѻý> From clinical inertia to future hope for advanced breast cancer Jul 05, 2017 video
<ѻý>Another CDK4/6 Inhibitor Boosts PFS in Breast Cancerѻý> Abemaciclib-fulvestrant combo for advanced HR+/HER2- disease Jun 08, 2017
<ѻý>No Survival Benefit with Node Dissection in Ovarian Caѻý> Macroscopic complete resection drives outcomes Jun 07, 2017
<ѻý>Two Anti-HER2 Drugs Slightly Better Than Oneѻý> Patient selection key to addition of pertuzumab to trastuzumab Jun 07, 2017
<ѻý>Genomic Testing Helps Cancer Patients -- When Results are Usedѻý> Also, liquid biopsy can ID drug-responsive tumors Jun 06, 2017
<ѻý>Dacomitinib Sets PFS Record in Phase III NSCLC Trialѻý> Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy Jun 06, 2017
<ѻý>CAR T Cells Drive Outcomes in MMѻý> Studies show promise for precision immunotherapy Jun 06, 2017
<ѻý>Immunotherapy Shows Promise in Tough-to-Treat Mesotheliomaѻý> Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients Jun 05, 2017
<ѻý>Advanced Ca Patients Benefit from Online Symptom Reportsѻý> Patient-reported outcomes tied to increased survival Jun 05, 2017
<ѻý>Trastuzumab Copycat Has Similar Efficacyѻý> Phase III trial compared substances in early-stage breast cancer Jun 05, 2017
<ѻý>Big Win for PARP Inhibitor in Breast Cancerѻý> PFS boost for HER2-negative, BRCA-mutated disease Jun 05, 2017
<ѻý>Morning Break: Tainted Trials; $40K/Yr Concierge Practice; Reality TV: Diabetesѻý> Health news and commentary from around the Web gathered by the ѻý staff Jun 05, 2017
<ѻý>Short-Course RT Helps Retain Ability to Walk in Advanced Caѻý> Preferable to multi-dose radiotherapy for spinal cord compression Jun 04, 2017
<ѻý>Novel Agent Shows Antitumor Activity in TRK-Fusion Cancersѻý> Tumor genetics define treatment approach in early-stage trials Jun 04, 2017
<ѻý>Mixed Results with Novel Tx in Sarcomaѻý> Aldodoxorubicin can't boost PFS, but promising in L-sarcomas Jun 03, 2017
<ѻý>Abiraterone Combo: A New Care Standard in Prostate Cancer?ѻý> Earlier treatment appears to improve survival in metastatic disease Jun 03, 2017
<ѻý>Second Surgery Slows Recurrent Ovarian Cancerѻý> But no survival gain seen in interim analysis of DESKTOP III Jun 03, 2017
<ѻý>Psychosocial Interventions Help Cancer Patients Copeѻý> Programs focus on lowering fear of recurrence, managing advanced disease Jun 03, 2017